trending Market Intelligence /marketintelligence/en/news-insights/trending/akg3tswxxw5ctvbjblzwyq2 content esgSubNav
In This List

Coherus BioSciences appoints former Anthem exec to board

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Coherus BioSciences appoints former Anthem exec to board

Coherus Biosciences Inc. appointed Samuel Nussbaum to its board of directors.

The appointee is the former vice president of clinical health policy and chief medical officer of Anthem Inc., having served in those roles from 2000 to 2016.

The Redwood City, Calif.-based company said Nussbaum's appointment will help with Coherus' efforts to introduce its biosimilar medicines in the market.